These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7740878)

  • 1. [The role of hereditary, clinical and pharmacokinetic factors in predicting the prophylactic effect of lithium salts].
    Vartan'ian ME; Panteleeva GP; Gor'kov VA; Nikiforova IIu; Raiushkin VA; Rozova GI; Hippius H; Greil W; Catapano F; Maj M
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(6):52-8. PubMed ID: 7740878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative characteristics of the preventive properties of short-acting and delayed-action lithium carbonate in endogenous affective psychoses].
    Panteleeva GP; Mikhaĭlova NM; Beliaev BS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):406-12. PubMed ID: 6789585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy of lithium carbonate and Contemnol in preventing affective and schizoaffective psychoses].
    Mosolov SN; Kostiukova EG; Kuzavkova MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(3):15-8. PubMed ID: 9575624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative clinico-pharmacokinetic study of the use of equivalent daily doses of lithium carbonate and Contemnol].
    Mosolov SN; Kuzavkova MV; Uzbekov MG; Misionzhhnik EIu; Ryzhov AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(5):30-3. PubMed ID: 9245155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of nifedipine for overcoming the insufficient preventive effect of lithium carbonate in patients with affective and schizoaffective psychoses].
    Snedkova LV; Vasiuk VK; Fursov GG; Panteleeva GP
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(10):35-9. PubMed ID: 9424345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prophylactic lithium treatment in affective disorders and the possibilities of the outcome prediction.
    Hanus H; Zapletălek M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1984; 27(1):5-75. PubMed ID: 6599636
    [No Abstract]   [Full Text] [Related]  

  • 7. [The prophylactic effect of lithium salt in affective psychoses with special references to patients with therapeutic failures].
    Krzyzowski J; Skaryszewska J; Marcjan K
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():235-8. PubMed ID: 829629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of verapamil for the prevention of relapses of affective and schizoaffective psychoses].
    Raiushkin VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(7):29-34. PubMed ID: 9721375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A trial of the use of nifedipine for preventing relapses in affective and schizoaffective psychoses].
    Snedkova LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(1):61-6. PubMed ID: 8677723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of lithium prophylaxis in schizoaffective psychoses: application of a polydiagnostic approach.
    Maj M
    Acta Psychiatr Scand; 1984 Sep; 70(3):228-34. PubMed ID: 6437145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Unsolved problems in the indications for lithium prophylaxis in affective and schizoaffective disorders].
    Angst J
    Bibl Psychiatr; 1981; (161):32-44. PubMed ID: 7271758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of affective psychoses response to lithium prophylaxis. The role of socio-demographic, clinical, psychological and biological variables.
    Maj M; Del Vecchio M; Starace F; Pirozzi R; Kemali D
    Acta Psychiatr Scand; 1984 Jan; 69(1):37-44. PubMed ID: 6422702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT brain function in affective disorder: d,l-fenfluramine-induced hormone release and clinical outcome in long-term lithium/carbamazepine prophylaxis.
    Mannel M; Müller-Oerlinghausen B; Czernik A; Sauer H
    J Affect Disord; 1997 Nov; 46(2):101-13. PubMed ID: 9479614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium response and genetics of affective disorders.
    Grof P; Alda M; Grof E; Zvolsky P; Walsh M
    J Affect Disord; 1994 Oct; 32(2):85-95. PubMed ID: 7829768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative features of the preventive action of carbamazepine and lithium carbonate in affective and schizoaffective psychoses].
    Kostiukova EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(12):64-71. PubMed ID: 2517374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Individual prognosis in endogenous affective and schizoaffective psychoses: clinical predictors].
    Evsegneev RA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(1):78-81. PubMed ID: 1319658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of clinical and pharmacokinetic parameters in predicting the effectiveness of lithium salts in patients with affective psychoses].
    Minsker EI; Panteleeva GP; Gindilis VM; Mikhaĭlova NM; Beliaev BS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(8):1209-14. PubMed ID: 899533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thyroid function in long-term use of lithium salts for prevention of recurrence of affective disorders].
    Wasilewski B
    Psychiatr Pol; 1982; 16(3):113-9. PubMed ID: 6817355
    [No Abstract]   [Full Text] [Related]  

  • 19. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term lithium prophylaxis in the bipolar affective disorder].
    Suwalska A; Chłopocka-Woźniak M; Rybakowski J
    Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.